VersaTrial Bolsters Advisory Board with Appointment of Erin O'Boyle

WILTON, Connecticut, June 12, 2023 – VersaTrial, the clinical research site enablement and engagement platform, is delighted to announce the appointment of Erin O'Boyle to its advisory board.

Erin O’Boyle, an industry veteran with almost two decades of operational and management experience in clinical research and development, will bring her unique expertise and insight to VersaTrial. Having led clinical operations in diverse therapeutic areas like oncology, anemia, rare diseases and ophthalmology, her experience will contribute to VersaTrial's ongoing development and growth. 

"I am truly honored to join the VersaTrial advisory board," says O’Boyle. "VersaTrial's commitment to streamlining and strengthening clinical research resonates with my passion for this field. Their innovative platform simplifies research site activities, helping teams focus more on patients and less on navigating complex systems. The transparency and collaboration that VersaTrial brings to the Site-Sponsor-CRO relationship is transformative. I look forward to contributing my expertise towards their mission of unlocking faster and more efficient clinical trials."

VersaTrial founder and CEO, Mike Wenger, expressed his enthusiasm for O'Boyle's appointment. "We are thrilled to welcome Erin to our advisory board. Her broad clinical operations experience, coupled with her hands-on knowledge of the challenges and opportunities in the industry, makes her an invaluable addition to our team. Erin's guidance will be instrumental in our continued efforts to empower research sites, improve productivity, and ultimately accelerate the pace of clinical trials."

VersaTrial is fast becoming an indispensable tool for research sites and sponsors, aiding with everything from seamless access to study information to simplifying contact sharing, study startup processes and business development activities.

About VersaTrial

VersaTrial is the all-in-one site portal that lets Sponsors and CROs improve clinical trial speed, quality, and collaboration. Enabling sites to spend more time with patients and less time navigating technology systems unlocks faster trials with fewer mistakes, wider tech adoption, and stronger site relationships. Only VersaTrial’s clinical trial site engagement platform provides Sponsors and CROs with real-time operational insights, bi-directional communication, and access management alerts to ensure measurable partner oversight and quality execution. Learn more at https://www.versatrial.io